APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurokinin Receptor Antagonists API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neurokinin Receptor Antagonists API Industry Growth and Trends Forecast to 2032

28 December 2025129 pages

Choose your research edition.

Industry ResearchNeurokinin Receptor Antagonists API Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurokinin Receptor Antagonists API Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Neurokinin Receptor Antagonists API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurokinin Receptor Antagonists API Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurokinin Receptor Antagonists API Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Neurokinin Receptor Antagonists API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neurokinin Receptor Antagonists API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neurokinin Receptor Antagonists API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurokinin Receptor Antagonists API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurokinin Receptor Antagonists API include Zhejiang Tiantai Pharmaceutical, Humanwell Pharmaceutical, Viwit, Sichuan Qingmu Pharmaceutical, Kelun Pharmaceutical, Shandong New Time Pharmaceutical, Shandong Anxin Pharmaceutical, Qilu Pharmaceutical and Luoxin Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neurokinin Receptor Antagonists API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neurokinin Receptor Antagonists API market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neurokinin Receptor Antagonists API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neurokinin Receptor Antagonists API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neurokinin Receptor Antagonists API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neurokinin Receptor Antagonists API Market by Company

Zhejiang Tiantai Pharmaceutical

Humanwell Pharmaceutical

Viwit

Sichuan Qingmu Pharmaceutical

Kelun Pharmaceutical

Shandong New Time Pharmaceutical

Shandong Anxin Pharmaceutical

Qilu Pharmaceutical

Luoxin Pharmaceuticals

Lianyungang Runzhong Pharmaceutical

Wisdom Pharmaceutical

Hansoh Pharma

United Pharma

Hangzhou Jiuyuan Gene Engineering

Beijing Sjar Technology Development

Zydus Animal Health And Investments

Taizhou Crene Biotechnology

Solara Active Pharma Sciences

Procos

Piramal Pharma

Optimus Pharma

Murli Krishna Pharma

MSN Laboratories

Jubilant Pharmova

Helsinn Advanced Synthesis

Glenmark Life Sciences

Dr. Reddy's Laboratories

Clearsynth Labs

Camus Pharma

Andenex

Neurokinin Receptor Antagonists API Segment by Type

Aprepitant

Fezolinetant

Fosaprepitant

Rolapitant

Maropitant

Netupitant

Neurokinin Receptor Antagonists API Segment by Application

Injections

Tablets

Oral Suspension

Capsules

Other

Neurokinin Receptor Antagonists API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurokinin Receptor Antagonists API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurokinin Receptor Antagonists API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurokinin Receptor Antagonists API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurokinin Receptor Antagonists API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neurokinin Receptor Antagonists API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Aprepitant Table 2. Major Company of Fezolinetant Table 3. Major Company of Fosaprepitant Table 4. Major Company of Rolapitant Table 5. Major Company of Maropitant Table 6. Major Company of Netupitant Table 7. Global Neurokinin Receptor Antagonists API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 9. Global Neurokinin Receptor Antagonists API Sales Market Share in Volume by Type (2021-2026) Table 10. Global Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (US$ Million) Table 11. Global Neurokinin Receptor Antagonists API Sales Market Share in Value by Type (2021-2026) Table 12. Global Neurokinin Receptor Antagonists API Price by Type (2021-2026) & (US$/Kg) Table 13. Global Neurokinin Receptor Antagonists API Sales by Type (2027-2032) & (Tons) Table 14. Global Neurokinin Receptor Antagonists API Sales Market Share in Volume by Type (2027-2032) Table 15. Global Neurokinin Receptor Antagonists API Sales by Type (2027-2032) & (US$ Million) Table 16. Global Neurokinin Receptor Antagonists API Sales Market Share in Value by Type (2027-2032) Table 17. Global Neurokinin Receptor Antagonists API Price by Type (2027-2032) & (US$/Kg) Table 18. North America Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 19. North America Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 21. Europe Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 23. Asia-Pacific Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 25. Latin America Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 27. Middle East and Africa Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (US$ Million) Table 28. Neurokinin Receptor Antagonists API Industry Trends Table 29. Neurokinin Receptor Antagonists API Industry Drivers Table 30. Neurokinin Receptor Antagonists API Industry Opportunities and Challenges Table 31. Neurokinin Receptor Antagonists API Industry Restraints Table 32. Global Neurokinin Receptor Antagonists API Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Neurokinin Receptor Antagonists API Revenue Market Share by Company (2021-2026) Table 34. Global Neurokinin Receptor Antagonists API Sales by Company (2021-2026) & (Tons) Table 35. Global Neurokinin Receptor Antagonists API Sales Share by Company (2021-2026) Table 36. Global Neurokinin Receptor Antagonists API Market Price by Company (2021-2026) & (US$/Kg) Table 37. Global Neurokinin Receptor Antagonists API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Neurokinin Receptor Antagonists API Major Company Production Sites and Headquarters Table 39. Global Neurokinin Receptor Antagonists API Company, Product Type & Application Table 40. Global Neurokinin Receptor Antagonists API Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Neurokinin Receptor Antagonists API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Neurokinin Receptor Antagonists API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Neurokinin Receptor Antagonists API Sales by Region (2021-2026) & (Tons) Table 45. Global Neurokinin Receptor Antagonists API Sales Market Share in Volume by Region (2021-2026) Table 46. Global Neurokinin Receptor Antagonists API Sales by Region (2021-2026) & (US$ Million) Table 47. Global Neurokinin Receptor Antagonists API Sales Market Share in Value by Region (2021-2026) Table 48. Global Neurokinin Receptor Antagonists API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 49. Global Neurokinin Receptor Antagonists API Sales by Region (2027-2032) & (Tons) Table 50. Global Neurokinin Receptor Antagonists API Sales Market Share in Volume by Region (2027-2032) Table 51. Global Neurokinin Receptor Antagonists API Sales by Region (2027-2032) & (US$ Million) Table 52. Global Neurokinin Receptor Antagonists API Sales Market Share in Value by Region (2027-2032) Table 53. Global Neurokinin Receptor Antagonists API Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 54. Global Neurokinin Receptor Antagonists API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 56. Global Neurokinin Receptor Antagonists API Sales Market Share in Volume by Application (2021-2026) Table 57. Global Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (US$ Million) Table 58. Global Neurokinin Receptor Antagonists API Sales Market Share in Value by Application (2021-2026) Table 59. Global Neurokinin Receptor Antagonists API Price by Application (2021-2026) & (US$/Kg) Table 60. Global Neurokinin Receptor Antagonists API Sales by Application (2027-2032) & (Tons) Table 61. Global Neurokinin Receptor Antagonists API Sales Market Share in Volume by Application (2027-2032) Table 62. Global Neurokinin Receptor Antagonists API Sales by Application (2027-2032) & (US$ Million) Table 63. Global Neurokinin Receptor Antagonists API Sales Market Share in Value by Application (2027-2032) Table 64. Global Neurokinin Receptor Antagonists API Price by Application (2027-2032) & (US$/Kg) Table 65. North America Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 66. North America Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 68. Europe Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 70. Asia-Pacific Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 72. Latin America Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 74. Middle East and Africa Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (US$ Million) Table 75. Zhejiang Tiantai Pharmaceutical Company Information Table 76. Zhejiang Tiantai Pharmaceutical Business Overview Table 77. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 78. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 79. Zhejiang Tiantai Pharmaceutical Recent Development Table 80. Humanwell Pharmaceutical Company Information Table 81. Humanwell Pharmaceutical Business Overview Table 82. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 83. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 84. Humanwell Pharmaceutical Recent Development Table 85. Viwit Company Information Table 86. Viwit Business Overview Table 87. Viwit Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 88. Viwit Neurokinin Receptor Antagonists API Product Portfolio Table 89. Viwit Recent Development Table 90. Sichuan Qingmu Pharmaceutical Company Information Table 91. Sichuan Qingmu Pharmaceutical Business Overview Table 92. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 93. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 94. Sichuan Qingmu Pharmaceutical Recent Development Table 95. Kelun Pharmaceutical Company Information Table 96. Kelun Pharmaceutical Business Overview Table 97. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 98. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 99. Kelun Pharmaceutical Recent Development Table 100. Shandong New Time Pharmaceutical Company Information Table 101. Shandong New Time Pharmaceutical Business Overview Table 102. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 103. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 104. Shandong New Time Pharmaceutical Recent Development Table 105. Shandong Anxin Pharmaceutical Company Information Table 106. Shandong Anxin Pharmaceutical Business Overview Table 107. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 108. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 109. Shandong Anxin Pharmaceutical Recent Development Table 110. Qilu Pharmaceutical Company Information Table 111. Qilu Pharmaceutical Business Overview Table 112. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 113. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 114. Qilu Pharmaceutical Recent Development Table 115. Luoxin Pharmaceuticals Company Information Table 116. Luoxin Pharmaceuticals Business Overview Table 117. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 118. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product Portfolio Table 119. Luoxin Pharmaceuticals Recent Development Table 120. Lianyungang Runzhong Pharmaceutical Company Information Table 121. Lianyungang Runzhong Pharmaceutical Business Overview Table 122. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 123. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 124. Lianyungang Runzhong Pharmaceutical Recent Development Table 125. Wisdom Pharmaceutical Company Information Table 126. Wisdom Pharmaceutical Business Overview Table 127. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 128. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 129. Wisdom Pharmaceutical Recent Development Table 130. Hansoh Pharma Company Information Table 131. Hansoh Pharma Business Overview Table 132. Hansoh Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 133. Hansoh Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 134. Hansoh Pharma Recent Development Table 135. United Pharma Company Information Table 136. United Pharma Business Overview Table 137. United Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 138. United Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 139. United Pharma Recent Development Table 140. Hangzhou Jiuyuan Gene Engineering Company Information Table 141. Hangzhou Jiuyuan Gene Engineering Business Overview Table 142. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 143. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product Portfolio Table 144. Hangzhou Jiuyuan Gene Engineering Recent Development Table 145. Beijing Sjar Technology Development Company Information Table 146. Beijing Sjar Technology Development Business Overview Table 147. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 148. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product Portfolio Table 149. Beijing Sjar Technology Development Recent Development Table 150. Zydus Animal Health And Investments Company Information Table 151. Zydus Animal Health And Investments Business Overview Table 152. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 153. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product Portfolio Table 154. Zydus Animal Health And Investments Recent Development Table 155. Taizhou Crene Biotechnology Company Information Table 156. Taizhou Crene Biotechnology Business Overview Table 157. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 158. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product Portfolio Table 159. Taizhou Crene Biotechnology Recent Development Table 160. Solara Active Pharma Sciences Company Information Table 161. Solara Active Pharma Sciences Business Overview Table 162. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 163. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product Portfolio Table 164. Solara Active Pharma Sciences Recent Development Table 165. Procos Company Information Table 166. Procos Business Overview Table 167. Procos Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 168. Procos Neurokinin Receptor Antagonists API Product Portfolio Table 169. Procos Recent Development Table 170. Piramal Pharma Company Information Table 171. Piramal Pharma Business Overview Table 172. Piramal Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 173. Piramal Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 174. Piramal Pharma Recent Development Table 175. Optimus Pharma Company Information Table 176. Optimus Pharma Business Overview Table 177. Optimus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 178. Optimus Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 179. Optimus Pharma Recent Development Table 180. Murli Krishna Pharma Company Information Table 181. Murli Krishna Pharma Business Overview Table 182. Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 183. Murli Krishna Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 184. Murli Krishna Pharma Recent Development Table 185. MSN Laboratories Company Information Table 186. MSN Laboratories Business Overview Table 187. MSN Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 188. MSN Laboratories Neurokinin Receptor Antagonists API Product Portfolio Table 189. MSN Laboratories Recent Development Table 190. Jubilant Pharmova Company Information Table 191. Jubilant Pharmova Business Overview Table 192. Jubilant Pharmova Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 193. Jubilant Pharmova Neurokinin Receptor Antagonists API Product Portfolio Table 194. Jubilant Pharmova Recent Development Table 195. Helsinn Advanced Synthesis Company Information Table 196. Helsinn Advanced Synthesis Business Overview Table 197. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 198. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product Portfolio Table 199. Helsinn Advanced Synthesis Recent Development Table 200. Glenmark Life Sciences Company Information Table 201. Glenmark Life Sciences Business Overview Table 202. Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 203. Glenmark Life Sciences Neurokinin Receptor Antagonists API Product Portfolio Table 204. Glenmark Life Sciences Recent Development Table 205. Dr. Reddy's Laboratories Company Information Table 206. Dr. Reddy's Laboratories Business Overview Table 207. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 208. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product Portfolio Table 209. Dr. Reddy's Laboratories Recent Development Table 210. Clearsynth Labs Company Information Table 211. Clearsynth Labs Business Overview Table 212. Clearsynth Labs Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 213. Clearsynth Labs Neurokinin Receptor Antagonists API Product Portfolio Table 214. Clearsynth Labs Recent Development Table 215. Camus Pharma Company Information Table 216. Camus Pharma Business Overview Table 217. Camus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 218. Camus Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 219. Camus Pharma Recent Development Table 220. Andenex Company Information Table 221. Andenex Business Overview Table 222. Andenex Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 223. Andenex Neurokinin Receptor Antagonists API Product Portfolio Table 224. Andenex Recent Development Table 225. North America Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 226. North America Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons) Table 227. North America Neurokinin Receptor Antagonists API Sales Market Share by Country (2021-2026) Table 228. North America Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons) Table 229. North America Neurokinin Receptor Antagonists API Sales Market Share Forecast by Country (2027-2032) Table 230. North America Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 231. North America Neurokinin Receptor Antagonists API Market Size by Country (2021-2026) & (US$ Million) Table 232. North America Neurokinin Receptor Antagonists API Market Share by Country (2021-2026) Table 233. North America Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 234. North America Neurokinin Receptor Antagonists API Market Share Forecast by Country (2027-2032) Table 235. Europe Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 236. Europe Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons) Table 237. Europe Neurokinin Receptor Antagonists API Sales Market Share by Country (2021-2026) Table 238. Europe Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons) Table 239. Europe Neurokinin Receptor Antagonists API Sales Market Share Forecast by Country (2027-2032) Table 240. Europe Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 241. Europe Neurokinin Receptor Antagonists API Market Size by Country (2021-2026) & (US$ Million) Table 242. Europe Neurokinin Receptor Antagonists API Market Share by Country (2021-2026) Table 243. Europe Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 244. Europe Neurokinin Receptor Antagonists API Market Share Forecast by Country (2027-2032) Table 245. Asia-Pacific Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 246. Asia-Pacific Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons) Table 247. Asia-Pacific Neurokinin Receptor Antagonists API Sales Market Share by Country (2021-2026) Table 248. Asia-Pacific Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons) Table 249. Asia-Pacific Neurokinin Receptor Antagonists API Sales Market Share Forecast by Country (2027-2032) Table 250. Asia-Pacific Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 251. Asia-Pacific Neurokinin Receptor Antagonists API Market Size by Country (2021-2026) & (US$ Million) Table 252. Asia-Pacific Neurokinin Receptor Antagonists API Market Share by Country (2021-2026) Table 253. Asia-Pacific Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 254. Asia-Pacific Neurokinin Receptor Antagonists API Market Share Forecast by Country (2027-2032) Table 255. Latin America Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 256. Latin America Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons) Table 257. Latin America Neurokinin Receptor Antagonists API Sales Market Share by Country (2021-2026) Table 258. Latin America Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons) Table 259. Latin America Neurokinin Receptor Antagonists API Sales Market Share Forecast by Country (2027-2032) Table 260. Latin America Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 261. Latin America Neurokinin Receptor Antagonists API Market Size by Country (2021-2026) & (US$ Million) Table 262. Latin America Neurokinin Receptor Antagonists API Market Share by Country (2021-2026) Table 263. Latin America Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 264. Latin America Neurokinin Receptor Antagonists API Market Share Forecast by Country (2027-2032) Table 265. Middle East and Africa Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 266. Middle East and Africa Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons) Table 267. Middle East and Africa Neurokinin Receptor Antagonists API Sales Market Share by Country (2021-2026) Table 268. Middle East and Africa Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons) Table 269. Middle East and Africa Neurokinin Receptor Antagonists API Sales Market Share Forecast by Country (2027-2032) Table 270. Middle East and Africa Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 271. Middle East and Africa Neurokinin Receptor Antagonists API Market Size by Country (2021-2026) & (US$ Million) Table 272. Middle East and Africa Neurokinin Receptor Antagonists API Market Share by Country (2021-2026) Table 273. Middle East and Africa Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 274. Middle East and Africa Neurokinin Receptor Antagonists API Market Share Forecast by Country (2027-2032) Table 275. Key Raw Materials Table 276. Raw Materials Key Suppliers Table 277. Neurokinin Receptor Antagonists API Distributors List Table 278. Neurokinin Receptor Antagonists API Customers List Table 279. Research Programs/Design for This Report Table 280. Authors List of This Report Table 281. Secondary Sources Table 282. Primary Sources List of Figures Figure 1. Neurokinin Receptor Antagonists API Image Figure 2. Global Neurokinin Receptor Antagonists API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurokinin Receptor Antagonists API Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurokinin Receptor Antagonists API Sales (2021-2032) & (Tons) Figure 5. Aprepitant Image Figure 6. Global Aprepitant Sales YoY Growth (2021-2032) & (Tons) Figure 7. Fezolinetant Image Figure 8. Global Fezolinetant Sales YoY Growth (2021-2032) & (Tons) Figure 9. Fosaprepitant Image Figure 10. Global Fosaprepitant Sales YoY Growth (2021-2032) & (Tons) Figure 11. Rolapitant Image Figure 12. Global Rolapitant Sales YoY Growth (2021-2032) & (Tons) Figure 13. Maropitant Image Figure 14. Global Maropitant Sales YoY Growth (2021-2032) & (Tons) Figure 15. Netupitant Image Figure 16. Global Netupitant Sales YoY Growth (2021-2032) & (Tons) Figure 17. Global Neurokinin Receptor Antagonists API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Neurokinin Receptor Antagonists API Market Share by Type 2025 VS 2032 Figure 19. North America Neurokinin Receptor Antagonists API Sales Market Share in Volume by Type in 2025 Figure 20. North America Neurokinin Receptor Antagonists API Sales Market Share in Value by Type in 2025 Figure 21. Europe Neurokinin Receptor Antagonists API Sales Market Share in Volume by Type in 2025 Figure 22. Europe Neurokinin Receptor Antagonists API Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Neurokinin Receptor Antagonists API Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Neurokinin Receptor Antagonists API Sales Market Share in Value by Type in 2025 Figure 25. Latin America Neurokinin Receptor Antagonists API Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Neurokinin Receptor Antagonists API Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Neurokinin Receptor Antagonists API Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Neurokinin Receptor Antagonists API Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Neurokinin Receptor Antagonists API Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Injections Image Figure 32. Global Injections Sales YoY Growth (2021-2032) & (Tons) Figure 33. Tablets Image Figure 34. Global Tablets Sales YoY Growth (2021-2032) & (Tons) Figure 35. Oral Suspension Image Figure 36. Global Oral Suspension Sales YoY Growth (2021-2032) & (Tons) Figure 37. Capsules Image Figure 38. Global Capsules Sales YoY Growth (2021-2032) & (Tons) Figure 39. Other Image Figure 40. Global Other Sales YoY Growth (2021-2032) & (Tons) Figure 41. Global Neurokinin Receptor Antagonists API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Neurokinin Receptor Antagonists API Market Share by Application 2025 VS 2032 Figure 43. North America Neurokinin Receptor Antagonists API Sales Market Share in Volume by Application in 2025 Figure 44. North America Neurokinin Receptor Antagonists API Sales Market Share in Value by Application in 2025 Figure 45. Europe Neurokinin Receptor Antagonists API Sales Market Share in Volume by Application in 2025 Figure 46. Europe Neurokinin Receptor Antagonists API Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Neurokinin Receptor Antagonists API Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Neurokinin Receptor Antagonists API Sales Market Share in Value by Application in 2025 Figure 49. Latin America Neurokinin Receptor Antagonists API Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Neurokinin Receptor Antagonists API Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Neurokinin Receptor Antagonists API Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Neurokinin Receptor Antagonists API Sales Market Share in Value by Application in 2025 Figure 53. North America Neurokinin Receptor Antagonists API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. North America Neurokinin Receptor Antagonists API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Neurokinin Receptor Antagonists API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Neurokinin Receptor Antagonists API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Neurokinin Receptor Antagonists API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Europe Neurokinin Receptor Antagonists API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Neurokinin Receptor Antagonists API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Neurokinin Receptor Antagonists API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Neurokinin Receptor Antagonists API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 62. Asia-Pacific Neurokinin Receptor Antagonists API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Neurokinin Receptor Antagonists API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Neurokinin Receptor Antagonists API Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Neurokinin Receptor Antagonists API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 66. Latin America Neurokinin Receptor Antagonists API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Neurokinin Receptor Antagonists API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Neurokinin Receptor Antagonists API Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Neurokinin Receptor Antagonists API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 70. Middle East and Africa Neurokinin Receptor Antagonists API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Neurokinin Receptor Antagonists API Market Si

Scope & coverage.

Types
  • Aprepitant
  • Fezolinetant
  • Fosaprepitant
  • Rolapitant
  • Maropitant
  • Netupitant
Applications
  • Injections
  • Tablets
  • Oral Suspension
  • Capsules
  • Other
Companies covered
  • Zhejiang Tiantai Pharmaceutical
  • Humanwell Pharmaceutical
  • Viwit
  • Sichuan Qingmu Pharmaceutical
  • Kelun Pharmaceutical
  • Shandong New Time Pharmaceutical
  • Shandong Anxin Pharmaceutical
  • Qilu Pharmaceutical
  • Luoxin Pharmaceuticals
  • Lianyungang Runzhong Pharmaceutical
  • Wisdom Pharmaceutical
  • Hansoh Pharma
  • United Pharma
  • Hangzhou Jiuyuan Gene Engineering
  • Beijing Sjar Technology Development
  • Zydus Animal Health And Investments
  • Taizhou Crene Biotechnology
  • Solara Active Pharma Sciences
  • Procos
  • Piramal Pharma
  • Optimus Pharma
  • Murli Krishna Pharma
  • MSN Laboratories
  • Jubilant Pharmova
  • Helsinn Advanced Synthesis
  • Glenmark Life Sciences
  • Dr. Reddy's Laboratories
  • Clearsynth Labs
  • Camus Pharma
  • Andenex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurokinin Receptor Antagonists API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neurokinin Receptor Antagonists API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neurokinin Receptor Antagonists API Market by Type
  6. 1.3.1 Aprepitant
  7. 1.3.2 Fezolinetant
  8. 1.3.3 Fosaprepitant
  9. 1.3.4 Rolapitant
  10. 1.3.5 Maropitant
  11. 1.3.6 Netupitant
  12. 1.4 Global Neurokinin Receptor Antagonists API Market Size by Type
  13. 1.4.1 Global Neurokinin Receptor Antagonists API Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Neurokinin Receptor Antagonists API Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Neurokinin Receptor Antagonists API Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Neurokinin Receptor Antagonists API Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Neurokinin Receptor Antagonists API Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Neurokinin Receptor Antagonists API Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Neurokinin Receptor Antagonists API Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Neurokinin Receptor Antagonists API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neurokinin Receptor Antagonists API Industry Trends
  2. 2.2 Neurokinin Receptor Antagonists API Industry Drivers
  3. 2.3 Neurokinin Receptor Antagonists API Industry Opportunities and Challenges
  4. 2.4 Neurokinin Receptor Antagonists API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neurokinin Receptor Antagonists API Revenue (2021-2026)
  2. 3.2 Global Top Players by Neurokinin Receptor Antagonists API Sales (2021-2026)
  3. 3.3 Global Top Players by Neurokinin Receptor Antagonists API Price (2021-2026)
  4. 3.4 Global Neurokinin Receptor Antagonists API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurokinin Receptor Antagonists API Major Company Production Sites & Headquarters
  6. 3.6 Global Neurokinin Receptor Antagonists API Company, Product Type & Application
  7. 3.7 Global Neurokinin Receptor Antagonists API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurokinin Receptor Antagonists API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurokinin Receptor Antagonists API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurokinin Receptor Antagonists API Tier 1, Tier 2, and Tier 3
4 Neurokinin Receptor Antagonists API Regional Status and Outlook
  1. 4.1 Global Neurokinin Receptor Antagonists API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neurokinin Receptor Antagonists API Historic Market Size by Region
  3. 4.2.1 Global Neurokinin Receptor Antagonists API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neurokinin Receptor Antagonists API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neurokinin Receptor Antagonists API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neurokinin Receptor Antagonists API Forecasted Market Size by Region
  7. 4.3.1 Global Neurokinin Receptor Antagonists API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neurokinin Receptor Antagonists API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neurokinin Receptor Antagonists API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neurokinin Receptor Antagonists API by Application
  1. 5.1 Neurokinin Receptor Antagonists API Market by Application
  2. 5.1.1 Injections
  3. 5.1.2 Tablets
  4. 5.1.3 Oral Suspension
  5. 5.1.4 Capsules
  6. 5.1.5 Other
  7. 5.2 Global Neurokinin Receptor Antagonists API Market Size by Application
  8. 5.2.1 Global Neurokinin Receptor Antagonists API Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Neurokinin Receptor Antagonists API Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Neurokinin Receptor Antagonists API Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Neurokinin Receptor Antagonists API Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Neurokinin Receptor Antagonists API Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Neurokinin Receptor Antagonists API Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Neurokinin Receptor Antagonists API Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Neurokinin Receptor Antagonists API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Tiantai Pharmaceutical
  2. 6.1.1 Zhejiang Tiantai Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Tiantai Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  6. 6.1.5 Zhejiang Tiantai Pharmaceutical Recent Developments
  7. 6.2 Humanwell Pharmaceutical
  8. 6.2.1 Humanwell Pharmaceutical Company Information
  9. 6.2.2 Humanwell Pharmaceutical Business Overview
  10. 6.2.3 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  12. 6.2.5 Humanwell Pharmaceutical Recent Developments
  13. 6.3 Viwit
  14. 6.3.1 Viwit Company Information
  15. 6.3.2 Viwit Business Overview
  16. 6.3.3 Viwit Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Viwit Neurokinin Receptor Antagonists API Product Portfolio
  18. 6.3.5 Viwit Recent Developments
  19. 6.4 Sichuan Qingmu Pharmaceutical
  20. 6.4.1 Sichuan Qingmu Pharmaceutical Company Information
  21. 6.4.2 Sichuan Qingmu Pharmaceutical Business Overview
  22. 6.4.3 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  24. 6.4.5 Sichuan Qingmu Pharmaceutical Recent Developments
  25. 6.5 Kelun Pharmaceutical
  26. 6.5.1 Kelun Pharmaceutical Company Information
  27. 6.5.2 Kelun Pharmaceutical Business Overview
  28. 6.5.3 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  30. 6.5.5 Kelun Pharmaceutical Recent Developments
  31. 6.6 Shandong New Time Pharmaceutical
  32. 6.6.1 Shandong New Time Pharmaceutical Company Information
  33. 6.6.2 Shandong New Time Pharmaceutical Business Overview
  34. 6.6.3 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  36. 6.6.5 Shandong New Time Pharmaceutical Recent Developments
  37. 6.7 Shandong Anxin Pharmaceutical
  38. 6.7.1 Shandong Anxin Pharmaceutical Company Information
  39. 6.7.2 Shandong Anxin Pharmaceutical Business Overview
  40. 6.7.3 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  42. 6.7.5 Shandong Anxin Pharmaceutical Recent Developments
  43. 6.8 Qilu Pharmaceutical
  44. 6.8.1 Qilu Pharmaceutical Company Information
  45. 6.8.2 Qilu Pharmaceutical Business Overview
  46. 6.8.3 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  48. 6.8.5 Qilu Pharmaceutical Recent Developments
  49. 6.9 Luoxin Pharmaceuticals
  50. 6.9.1 Luoxin Pharmaceuticals Company Information
  51. 6.9.2 Luoxin Pharmaceuticals Business Overview
  52. 6.9.3 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product Portfolio
  54. 6.9.5 Luoxin Pharmaceuticals Recent Developments
  55. 6.10 Lianyungang Runzhong Pharmaceutical
  56. 6.10.1 Lianyungang Runzhong Pharmaceutical Company Information
  57. 6.10.2 Lianyungang Runzhong Pharmaceutical Business Overview
  58. 6.10.3 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  60. 6.10.5 Lianyungang Runzhong Pharmaceutical Recent Developments
  61. 6.11 Wisdom Pharmaceutical
  62. 6.11.1 Wisdom Pharmaceutical Company Information
  63. 6.11.2 Wisdom Pharmaceutical Business Overview
  64. 6.11.3 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  66. 6.11.5 Wisdom Pharmaceutical Recent Developments
  67. 6.12 Hansoh Pharma
  68. 6.12.1 Hansoh Pharma Company Information
  69. 6.12.2 Hansoh Pharma Business Overview
  70. 6.12.3 Hansoh Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hansoh Pharma Neurokinin Receptor Antagonists API Product Portfolio
  72. 6.12.5 Hansoh Pharma Recent Developments
  73. 6.13 United Pharma
  74. 6.13.1 United Pharma Company Information
  75. 6.13.2 United Pharma Business Overview
  76. 6.13.3 United Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 United Pharma Neurokinin Receptor Antagonists API Product Portfolio
  78. 6.13.5 United Pharma Recent Developments
  79. 6.14 Hangzhou Jiuyuan Gene Engineering
  80. 6.14.1 Hangzhou Jiuyuan Gene Engineering Company Information
  81. 6.14.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  82. 6.14.3 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product Portfolio
  84. 6.14.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  85. 6.15 Beijing Sjar Technology Development
  86. 6.15.1 Beijing Sjar Technology Development Company Information
  87. 6.15.2 Beijing Sjar Technology Development Business Overview
  88. 6.15.3 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product Portfolio
  90. 6.15.5 Beijing Sjar Technology Development Recent Developments
  91. 6.16 Zydus Animal Health And Investments
  92. 6.16.1 Zydus Animal Health And Investments Company Information
  93. 6.16.2 Zydus Animal Health And Investments Business Overview
  94. 6.16.3 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product Portfolio
  96. 6.16.5 Zydus Animal Health And Investments Recent Developments
  97. 6.17 Taizhou Crene Biotechnology
  98. 6.17.1 Taizhou Crene Biotechnology Company Information
  99. 6.17.2 Taizhou Crene Biotechnology Business Overview
  100. 6.17.3 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product Portfolio
  102. 6.17.5 Taizhou Crene Biotechnology Recent Developments
  103. 6.18 Solara Active Pharma Sciences
  104. 6.18.1 Solara Active Pharma Sciences Company Information
  105. 6.18.2 Solara Active Pharma Sciences Business Overview
  106. 6.18.3 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product Portfolio
  108. 6.18.5 Solara Active Pharma Sciences Recent Developments
  109. 6.19 Procos
  110. 6.19.1 Procos Company Information
  111. 6.19.2 Procos Business Overview
  112. 6.19.3 Procos Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Procos Neurokinin Receptor Antagonists API Product Portfolio
  114. 6.19.5 Procos Recent Developments
  115. 6.20 Piramal Pharma
  116. 6.20.1 Piramal Pharma Company Information
  117. 6.20.2 Piramal Pharma Business Overview
  118. 6.20.3 Piramal Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Piramal Pharma Neurokinin Receptor Antagonists API Product Portfolio
  120. 6.20.5 Piramal Pharma Recent Developments
  121. 6.21 Optimus Pharma
  122. 6.21.1 Optimus Pharma Company Information
  123. 6.21.2 Optimus Pharma Business Overview
  124. 6.21.3 Optimus Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Optimus Pharma Neurokinin Receptor Antagonists API Product Portfolio
  126. 6.21.5 Optimus Pharma Recent Developments
  127. 6.22 Murli Krishna Pharma
  128. 6.22.1 Murli Krishna Pharma Company Information
  129. 6.22.2 Murli Krishna Pharma Business Overview
  130. 6.22.3 Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Murli Krishna Pharma Neurokinin Receptor Antagonists API Product Portfolio
  132. 6.22.5 Murli Krishna Pharma Recent Developments
  133. 6.23 MSN Laboratories
  134. 6.23.1 MSN Laboratories Company Information
  135. 6.23.2 MSN Laboratories Business Overview
  136. 6.23.3 MSN Laboratories Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 MSN Laboratories Neurokinin Receptor Antagonists API Product Portfolio
  138. 6.23.5 MSN Laboratories Recent Developments
  139. 6.24 Jubilant Pharmova
  140. 6.24.1 Jubilant Pharmova Company Information
  141. 6.24.2 Jubilant Pharmova Business Overview
  142. 6.24.3 Jubilant Pharmova Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Jubilant Pharmova Neurokinin Receptor Antagonists API Product Portfolio
  144. 6.24.5 Jubilant Pharmova Recent Developments
  145. 6.25 Helsinn Advanced Synthesis
  146. 6.25.1 Helsinn Advanced Synthesis Company Information
  147. 6.25.2 Helsinn Advanced Synthesis Business Overview
  148. 6.25.3 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product Portfolio
  150. 6.25.5 Helsinn Advanced Synthesis Recent Developments
  151. 6.26 Glenmark Life Sciences
  152. 6.26.1 Glenmark Life Sciences Company Information
  153. 6.26.2 Glenmark Life Sciences Business Overview
  154. 6.26.3 Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Glenmark Life Sciences Neurokinin Receptor Antagonists API Product Portfolio
  156. 6.26.5 Glenmark Life Sciences Recent Developments
  157. 6.27 Dr. Reddy's Laboratories
  158. 6.27.1 Dr. Reddy's Laboratories Company Information
  159. 6.27.2 Dr. Reddy's Laboratories Business Overview
  160. 6.27.3 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product Portfolio
  162. 6.27.5 Dr. Reddy's Laboratories Recent Developments
  163. 6.28 Clearsynth Labs
  164. 6.28.1 Clearsynth Labs Company Information
  165. 6.28.2 Clearsynth Labs Business Overview
  166. 6.28.3 Clearsynth Labs Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  167. 6.28.4 Clearsynth Labs Neurokinin Receptor Antagonists API Product Portfolio
  168. 6.28.5 Clearsynth Labs Recent Developments
  169. 6.29 Camus Pharma
  170. 6.29.1 Camus Pharma Company Information
  171. 6.29.2 Camus Pharma Business Overview
  172. 6.29.3 Camus Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  173. 6.29.4 Camus Pharma Neurokinin Receptor Antagonists API Product Portfolio
  174. 6.29.5 Camus Pharma Recent Developments
  175. 6.30 Andenex
  176. 6.30.1 Andenex Company Information
  177. 6.30.2 Andenex Business Overview
  178. 6.30.3 Andenex Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2021-2026)
  179. 6.30.4 Andenex Neurokinin Receptor Antagonists API Product Portfolio
  180. 6.30.5 Andenex Recent Developments
7 North America by Country
  1. 7.1 North America Neurokinin Receptor Antagonists API Sales by Country
  2. 7.1.1 North America Neurokinin Receptor Antagonists API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
  4. 7.1.3 North America Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neurokinin Receptor Antagonists API Market Size by Country
  6. 7.2.1 North America Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neurokinin Receptor Antagonists API Market Size by Country (2021-2026)
  8. 7.2.3 North America Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neurokinin Receptor Antagonists API Sales by Country
  2. 8.1.1 Europe Neurokinin Receptor Antagonists API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
  4. 8.1.3 Europe Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neurokinin Receptor Antagonists API Market Size by Country
  6. 8.2.1 Europe Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neurokinin Receptor Antagonists API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neurokinin Receptor Antagonists API Sales by Country
  2. 9.1.1 Asia-Pacific Neurokinin Receptor Antagonists API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neurokinin Receptor Antagonists API Market Size by Country
  6. 9.2.1 Asia-Pacific Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neurokinin Receptor Antagonists API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neurokinin Receptor Antagonists API Sales by Country
  2. 10.1.1 South America Neurokinin Receptor Antagonists API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
  4. 10.1.3 South America Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neurokinin Receptor Antagonists API Market Size by Country
  6. 10.2.1 South America Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neurokinin Receptor Antagonists API Market Size by Country (2021-2026)
  8. 10.2.3 South America Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neurokinin Receptor Antagonists API Sales by Country
  2. 11.1.1 Middle East and Africa Neurokinin Receptor Antagonists API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neurokinin Receptor Antagonists API Market Size by Country
  6. 11.2.1 Middle East and Africa Neurokinin Receptor Antagonists API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neurokinin Receptor Antagonists API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neurokinin Receptor Antagonists API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neurokinin Receptor Antagonists API Value Chain Analysis
  2. 12.1.1 Neurokinin Receptor Antagonists API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neurokinin Receptor Antagonists API Production Mode & Process
  7. 12.2 Neurokinin Receptor Antagonists API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neurokinin Receptor Antagonists API Distributors
  10. 12.2.3 Neurokinin Receptor Antagonists API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst